Skip to main content
. 2020 Jun 12;12(6):391. doi: 10.3390/toxins12060391

Table 1.

Inhibitory potencies of selected drugs on fluorescein uptake in ciPTEC-OAT1.

Drug IC50 (µM) a R Square b Therapeutic Concentrations (µM) [44]
ACEIs
Captopril 2022 ± 465 0.5557 0.2–5
Enalaprilate 1853 ± 370 0.6753 0.04–0.4
Lisinopril not available 0.1671 0.01–0.16
ARBs
Losartan 3.1 ± 0.7 0.8713 0.5–1.5
Valsartan 11.5 ± 3.5 0.9374 2–14
Diuretics
Furosemide 28.1 ± 9.1 0.9301 6–30
Statins
Pravastatin 13.8 ± 8.5 0.8757 0.08–0.3 [45]; 0.43 [46,47]
Simvastatin 21.3 ± 3.8 0.8613 0.006–0.014 [44]; 0.55 [46,47]
H2RA
Cimetidine 887.6 ± 198.4 0.7441 1–16

a Data are expressed as mean ± SD. b Curves were obtained after non-linear regression analysis. Abbreviations: ACEIs = angiotensin-converting enzyme inhibitors; ARBs = angiotensin receptor blockers; H2RA = histamine H2 receptor antagonists, IC50 = half maximal inhibitory concentration.